A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumor
Interventions: DRUG: Rucaparib
Sponsor: pharmaand GmbH